A 6-Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Safety and Efficacy Study of the Potential Inhibitory Effects on the Hypothalamic-Pituitary-Adrenal Axis of Ciclesonide HFA Nasal Aerosol and Ciclesonide Aqueous Nasal Spray in Subjects 12 Years and Older With Perennial Allergic Rhinitis.

Trial Profile

A 6-Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Safety and Efficacy Study of the Potential Inhibitory Effects on the Hypothalamic-Pituitary-Adrenal Axis of Ciclesonide HFA Nasal Aerosol and Ciclesonide Aqueous Nasal Spray in Subjects 12 Years and Older With Perennial Allergic Rhinitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jul 2012

At a glance

  • Drugs Ciclesonide (Primary) ; Dexamethasone
  • Indications Perennial allergic rhinitis
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Nov 2011 Results presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology.
    • 19 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top